Amicus Therapeutics Inc

General

Total Cases7
Active Cases7
Patents--
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
10/24/24
CONSENT JUDGMENT and PERMANENT INJUNCTION as to Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. (See Consent Judgment for further details.) Signed by Judge Christopher J. Burke on 10/24/2024. (smg) (Entered: 10/24/2024)
10/17/24
STIPULATION for Entry of Consent Judgment and Permanent Injunction as to Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # [1] Proposed Consent Judgment and Permanent Injunction)(Stover, Chad) (Entered: 10/17/2024)
10/03/24
ORDER GRANTING D.I. [182] Stipulation to Amend Scheduling Order filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. (A Pretrial Conference is set for 7/25/2025 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke. A 5-day Bench Trial is set for 8/4/2025 at 09:00 AM in Courtroom 2A before Judge Christopher J. Burke.) (See Order for further details and deadlines.) Signed by Judge Christopher J. Burke on 10/3/2024. (smg) (Entered: 10/03/2024)
09/26/24
STIPULATION to Amend Scheduling Order re [176] Stipulation, by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 09/26/2024)
09/19/24
STIPULATION TO EXTEND TIME to Provide the Court with Pretrial Conference and Trial Dates to September 26, 2024 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 09/19/2024)
09/19/24
SO ORDERED, D.I. [181] STIPULATION TO EXTEND TIME to Provide the Court with Pretrial Conference and Trial Dates to September 26, 2024 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 9/19/2024. (smg) (Entered: 09/19/2024)
09/12/24
NOTICE OF SERVICE of (1) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs First Set of Requests for Admission (Nos. 1-11); (2) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs Fourth Set of Interrogatories (Nos. 15-17); and (3) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 09/12/2024)
09/11/24
NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Interrogatory Nos. 7 & 16 filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 09/11/2024)
09/10/24
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Fed. R. Civ. P. 30(B)(6) Notice of Deposition filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 09/10/2024)
09/06/24
SO ORDERED, D.I. [176] Stipulation and Order to Amend Scheduling Order filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 9/5/2024. (smg) (Entered: 09/06/2024)